CHEK2 and colorectal carcinoma: In the present study, the expression of a panel of phospho-kinases analyzed by an antibody-based array suggested phosphorylated Chk2 (T68) to be an interaction partner of p21 that is involved in mediating 5FU resistance in CRC.